Literature DB >> 6720967

Mechanisms of escape from sodium retention during angiotensin II hypertension.

J E Hall, J P Granger, R L Hester, T G Coleman, M J Smith, R B Cross.   

Abstract

This study examined the role of increased renal arterial pressure (RAP) in renal escape from the chronic Na-retaining effects of angiotensin II (ANG II). When RAP was allowed to increase during ANG II infusion (5 ng X kg-1 X min-1), urinary Na excretion (UNaV) decreased transiently on the first day but there was no significant change in Na iothalamate space or cumulative Na balance when ANG II infusion was continued for 6 days. Mean arterial pressure (MAP) rose from 100 +/- 3 to 132 +/- 2 mmHg after 3 days and remained near that level for the next 5 days of ANG II infusion. When RAP was prevented from rising with a servo-controlled aortic occluder, UNaV remained below control even after 6 days of ANG II infusion, cumulative Na balance increased by 210 +/- 37 meq, and Na iothalamate space rose by 1,158 +/- 244 ml. MAP did not plateau when RAP was servo-controlled during ANG II infusion but continued to rise and after 6 days averaged 157 +/- 3 mmHg. In three of the eight dogs in which RAP was servo-controlled during ANG II infusion, Na and water retention became so severe that MAP increased to 165-180 mmHg and pulmonary edema developed within 4-6 days. These data suggest that a rise in RAP is essential in allowing the kidneys to escape from the chronic Na-retaining actions of ANG II and in attaining Na balance and a stable level of MAP without severe volume expansion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6720967     DOI: 10.1152/ajprenal.1984.246.5.F627

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 2.  Mechanisms of pressure natriuresis.

Authors:  Joey P Granger; Barbara T Alexander; Mayte Llinas
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

3.  Renal Dysfunction, Rather Than Nonrenal Vascular Dysfunction, Mediates Salt-Induced Hypertension.

Authors:  John E Hall
Journal:  Circulation       Date:  2016-03-01       Impact factor: 29.690

4.  Contribution of pressure natriuresis to control of total body sodium: balance studies in freely moving dogs.

Authors:  E Seeliger; E Safak; P B Persson; H W Reinhardt
Journal:  J Physiol       Date:  2001-12-15       Impact factor: 5.182

5.  Intrarenal angiotensin-converting enzyme induces hypertension in response to angiotensin I infusion.

Authors:  Romer A Gonzalez-Villalobos; Sandrine Billet; Catherine Kim; Ryousuke Satou; Sebastien Fuchs; Kenneth E Bernstein; L Gabriel Navar
Journal:  J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 10.121

Review 6.  Sympathetic neural mechanisms in human blood pressure regulation.

Authors:  Emma C Hart; Nisha Charkoudian
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

7.  A new mechanism for the sex differences in angiotensin II-induced hypertension: the role of macula densa NOS1β-mediated tubuloglomerular feedback.

Authors:  Jie Zhang; Larry Qu; Jin Wei; Shan Jiang; Lan Xu; Lei Wang; Feng Cheng; Kun Jiang; Jacentha Buggs; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2020-10-12

Review 8.  Causes and treatment of oedema in patients with heart failure.

Authors:  Andrew L Clark; John G F Cleland
Journal:  Nat Rev Cardiol       Date:  2013-01-15       Impact factor: 32.419

Review 9.  Role of angiotensin AT(2) receptors in natriuresis: Intrarenal mechanisms and therapeutic potential.

Authors:  Robert M Carey; Shetal H Padia
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-08       Impact factor: 2.557

10.  Enhanced distal nephron sodium reabsorption in chronic angiotensin II-infused mice.

Authors:  Di Zhao; Dale M Seth; L Gabriel Navar
Journal:  Hypertension       Date:  2009-06-01       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.